Showing results (41-50 of 49) with videos related to
Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Bioorganic & Medicinal Chemistry Letters|June 22, 2011
Applying the pro-drug approach to afford highly bioavailable antagonists of P2Y(14)Joël Robichaud, Jean-François Fournier, Sébastien Gagné, et al.Plos One|March 4, 2014
The dichotomous pattern of IL-12r and IL-23R expression elucidates the role of IL-12 and IL-23 in inflammationGaëlle Chognard, Lisa Bellemare, Adam-Nicolas Pelletier, et al.Plos One|May 14, 2010
The complete genome sequence of Cupriavidus metallidurans strain CH34, a master survivalist in harsh and anthropogenic environmentsPaul J Janssen, Rob Van Houdt, Hugo Moors, et al.Plos One|August 2, 2007
Cathepsin K null mice show reduced adiposity during the rapid accumulation of fat storesMarcella Funicello, Michela Novelli, Maurizio Ragni, et al.Genome Medicine|November 11, 2021
Functional screen of inflammatory bowel disease genes reveals key epithelial functionsJessy Carol Ntunzwenimana, Gabrielle Boucher, Jean Paquette, et al.Bioorganic & Medicinal Chemistry Letters|September 30, 2004
HCV NS5B polymerase-bound conformation of a soluble sulfonamide inhibitor by 2D transferred NOESYConstantin G Yannopoulos, Ping Xu, Feng Ni, et al.Bioorganic & Medicinal Chemistry Letters|April 22, 2011
Synthesis and SAR of pyrimidine-based, non-nucleotide P2Y14 receptor antagonistsDaniel Guay, Christian Beaulieu, Michel Belley, et al.Bioorganic & Medicinal Chemistry Letters|April 22, 2011
The identification of 4,7-disubstituted naphthoic acid derivatives as UDP-competitive antagonists of P2Y14Jacques Yves Gauthier, Michel Belley, Denis Deschênes, et al.Journal of Medicinal Chemistry|September 8, 2025
The Discovery of RP-2119: A Potent, Selective, and Orally Bioavailable Polθ ATPase InhibitorPhilippe Mochirian, Robert Papp, Marie-Claude Mathieu, et al.Pageof 5